Maxiflo 250 Rotacaps
Generic: Fluticasone/formoterolby Cipla Limited

Select pack size
Similar medicines
View allAbout Maxiflo 250 Rotacaps
Maxiflo 250 Rotacaps are dry powder inhalation capsules made in India by Cipla. Cipla's prescribing information says each capsule contains fluticasone propionate 250 mcg, an inhaled corticosteroid, and formoterol fumarate dihydrate 6 mcg, a long-acting bronchodilator, and that a sales pack holds 30 Rotacaps. The capsules are not swallowed: each one goes into a Rotahaler, which opens it so you can breathe in the powder. It is a twice daily preventer. We sell packs of 30, 60 and 90 capsules, from $0.42 a capsule in the 90 pack.
Two things to know before you order. First, no product with the same numbers is licensed in the US, UK, Australia or Canada. The licensed version of this combination is Flutiform, a pressurised inhaler sold in the UK and Australia for asthma only; we found no fluticasone with formoterol product approved by the FDA or authorised by Health Canada. Second, Cipla also lists Maxiflo 250 Rotacaps for severe COPD, but the UK Flutiform label says it "should not be used in patients with COPD" because there are no data. If you have COPD, that is a conversation for your doctor, not a reason to switch.
This page covers what "each capsule contains" means, how the dose compares with Flutiform, how to use the capsules with a Rotahaler, side effects, who should not use them, when to get urgent help and the price per capsule. Clinical figures come from Cipla's Maxiflo Rotacaps prescribing information and the UK summary of product characteristics for Flutiform, both listed at the end. We have not found a published study of Maxiflo Rotacaps against Flutiform.
Maxiflo 250 Rotacaps at a glance
| Active ingredients | Fluticasone propionate 250 mcg and formoterol fumarate dihydrate 6 mcg per capsule (Cipla prescribing information; the same numbers on Tata 1mg, PharmEasy, Apollo and Truemeds) |
| Brand and maker | Maxiflo, by Cipla Limited, India |
| Form | Dry powder capsules (Rotacaps) for a Rotahaler; 30 capsules in a container. The container in our product photo reads "For use with rotahaler". |
| Used for | Regular (maintenance) treatment of asthma; Cipla also lists severe COPD. Not a reliever. |
| Regulatory status | Fluticasone propionate with formoterol is licensed in the UK and Australia as the Flutiform inhaler (asthma only). We found no FDA approved or Health Canada authorised product with this combination. This Indian Maxiflo pack is not registered with the FDA, MHRA, TGA or Health Canada. |
| Usual dose (Cipla) | Asthma, adults and adolescents aged 12 and over: 1 to 2 capsules twice a day. COPD: 2 capsules twice a day. |
| Timing | Cipla says formoterol starts to open the airways within 1 to 3 minutes of a single dose and lasts at least 12 hours. It is still not for attacks (see below). |
| Packs | 30, 60 and 90 capsules (15, 30 and 45 days at 1 capsule twice a day, our arithmetic) |
| Price per capsule | $0.57 (30 pack) down to $0.42 (90 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per capsule
Prices below are as of November 2026; the pack selector shows the current price.
| Pack | Price | Per capsule | Shipping | Per capsule with shipping | Days at 1 capsule twice a day | Days at 2 capsules twice a day |
|---|---|---|---|---|---|---|
| 30 capsules | $17 | $0.57 | $25 | $1.40 | 15 | 7 and a half |
| 60 capsules | $26 | $0.43 | $25 | $0.85 | 30 | 15 |
| 90 capsules | $38 | $0.42 | $25 | $0.70 | 45 | 22 and a half |
All three packs are under the $149 free shipping threshold, so the flat $25 more than doubles what the 30 pack costs. The 60 and 90 packs cost almost the same per capsule before shipping; most of the gap with shipping comes from spreading the $25 over more capsules. The day counts are our arithmetic from Cipla's doses. At the COPD dose, or the upper asthma dose of 2 capsules twice a day, the 30 pack lasts under eight days, which is shorter than our delivery time.
You also need a Rotahaler. Our product photo shows a container of capsules and no device, so if you do not have one, add a Rotahaler ($6) to the order. Cipla says a Rotahaler can be used daily for up to 6 months and then replaced.
What "each capsule contains" means
Inhaled medicines are labelled in three different ways, and the numbers are easy to misread:
- Capsule content. Cipla's prescribing information gives what "each capsule contains": 250 mcg fluticasone propionate and 6 mcg formoterol fumarate dihydrate. That is the amount put into the capsule. It is neither a metered dose nor a delivered dose. Cipla's Rotahaler instructions tell you to breathe in again if some powder is left, which shows a capsule does not always empty in one breath. We found no figure from Cipla for how much leaves the Rotahaler.
- Metered dose. The UK Flutiform 250/10 inhaler is labelled by what each puff measures out at the valve: 250 mcg fluticasone propionate and 10 mcg formoterol fumarate dihydrate.
- Delivered dose. The same UK label says that puff delivers about 230 mcg fluticasone propionate and 9.0 mcg formoterol fumarate dihydrate from the mouthpiece.
So a Maxiflo 250 capsule and a Flutiform 250/10 puff share the fluticasone number but not the formoterol number, and they are counted in different ways. Treat any comparison below as a rough guide to the labelled amounts, not as proof that the same amount reaches your lungs.
Compared with Flutiform and what US patients use
| Maxiflo 250 Rotacaps | Flutiform 250/10 (UK, Australia) | US generic fluticasone propionate and salmeterol 250/50 | |
|---|---|---|---|
| Maker | Cipla, India | Napp Pharmaceuticals (UK licence holder) | Several makers (Wixela Inhub and others); brand Advair Diskus, GSK |
| Long-acting bronchodilator | Formoterol | Formoterol | Salmeterol (a different medicine) |
| Device | Capsules in a Rotahaler (dry powder) | Pressurised metered dose inhaler, 120 puffs | Dry powder inhaler with blisters |
| Labelled amount per dose | 250 mcg / 6 mcg per capsule (content) | 250 mcg / 10 mcg per puff (metered) | 250 mcg / 50 mcg per blister (blister content) |
| Licensed for COPD | Listed by Cipla for severe COPD | No: the UK label says not to use it in COPD | Yes, in the US (250/50) |
| Approved or registered with the FDA | No | No (not approved in the US) | Yes |
| Cost for 30 days at 1 dose twice a day | $26 for 60 capsules before shipping ($51 with shipping) | Not sold in the US | About $72 at the US pharmacy acquisition cost (NADAC $1.20791 per blister for generic 250/50, effective 21 October 2026); Advair Diskus 250/50 about $187 ($3.12178 per blister) |
NADAC is what US pharmacies pay, not the price you pay. The 30 day figures are our arithmetic (60 blisters times the per blister rate). Fluticasone with salmeterol is not the same medicine as fluticasone with formoterol, and a US prescription for one is not a prescription for the other. If you are in the US and have insurance, your copay for the generic may be lower than our price with shipping, so check it first. A switch between these products is a prescriber's decision.
How the dose compares with the Flutiform label
All figures in this section are our arithmetic from the labels, and they compare capsule content with metered puffs:
| Regimen | Fluticasone propionate a day | Formoterol fumarate dihydrate a day | Who the label allows |
|---|---|---|---|
| Maxiflo 250 Rotacaps, 1 capsule twice a day | 500 mcg (capsule content) | 12 mcg | Adults and adolescents 12 and over (Cipla) |
| Maxiflo 250 Rotacaps, 2 capsules twice a day | 1,000 mcg (capsule content) | 24 mcg | Adults and adolescents 12 and over with asthma; COPD dose (Cipla) |
| Flutiform 125/5, 2 puffs twice a day | 500 mcg metered | 20 mcg metered | Adults and adolescents 12 and over (UK) |
| Flutiform 250/10, 2 puffs twice a day (the UK maximum) | 1,000 mcg metered | 40 mcg metered | Adults only (UK) |
Two points follow. On fluticasone, 2 Maxiflo 250 capsules twice a day carry the same labelled amount as the highest Flutiform dose, which the UK label limits to adults; Cipla allows it from age 12. On formoterol, Maxiflo carries less per day than Flutiform at the same fluticasone dose. The Global Initiative for Asthma (GINA 2026) counts more than 500 mcg a day of fluticasone propionate from a dry powder inhaler as a high dose for adults and adolescents, and says its table shows suggested doses, not equivalence. Two capsules twice a day is therefore a high steroid dose and should only be taken on a doctor's advice.
Which strength to choose
| Product | Per capsule or puff | Cipla dose | Notes |
|---|---|---|---|
| Maxiflo 100 Rotacap | 100 mcg / 6 mcg (Cipla PI) | Adults and adolescents: 1 to 2 capsules twice a day | Lower steroid dose; Cipla's paediatric line is discussed below |
| Maxiflo 250 Rotacaps (this page) | 250 mcg / 6 mcg (Cipla PI) | Asthma: 1 to 2 capsules twice a day; COPD: 2 twice a day | Medium to high steroid dose |
| Maxiflo 125 Inhaler | Pressurised inhaler | Not covered by the Rotacaps PI | Different device; check the leaflet |
| Maxiflo 250 Inhaler | Pressurised inhaler | Not covered by the Rotacaps PI | Different device; check the leaflet |
Cipla's prescribing information gives a children's dose for Maxiflo 100 (one capsule twice a day from age 5), but its paediatric section says Maxiflo Rotacaps "are not recommended for children under 12 years". The two lines conflict, and Maxiflo 250 has no children's dose in either. The UK Flutiform label limits the 250/10 strength to adults. Maxiflo 250 is not a children's strength.
The UK label says the dose "should be titrated to the lowest dose at which effective control of symptoms is maintained", and Cipla says to step down after about 3 months of good control. Moving between strengths, or between capsules and a pressurised inhaler, is a decision for your doctor.
COPD: Cipla and the UK label disagree
Cipla lists Maxiflo Rotacaps for "patients with severe COPD" at 2 Maxiflo 250 capsules twice a day. India's drug regulator approved formoterol 6 mcg with fluticasone propionate 100, 250 or 500 mcg as a dry powder inhaler and metered dose inhaler "For Asthma & COPD" on 5 October 2006 (CDSCO fixed dose combination list, item 533). The UK Flutiform label says: "There are no data available for use of Flutiform inhaler in patients with COPD. Flutiform inhaler should not be used in patients with COPD." The Australian listing for Flutiform names asthma only. If you have COPD and are thinking about this product, ask your doctor first; licensed COPD inhalers with other ingredients exist in all four countries we ship to.
Not a reliever, and not a first treatment
Formoterol is a long-acting beta agonist (LABA). Combination inhalers like this are meant for people whose asthma needs both a steroid and a LABA, not for people starting treatment:
- The UK Flutiform label says it "should not be used as the first treatment for asthma", that "Inhaled corticosteroids alone are the first line of treatment for most patients", and that it "is not intended for the initial treatment of mild asthma".
- Cipla says Maxiflo Rotacaps "should not be used to treat acute asthma symptoms for which a fast and short-acting bronchodilator is required" and that patients should have their relief medicine "available at all times".
- Both labels say not to start it during an exacerbation or when asthma is significantly worsening or acutely deteriorating, and that serious asthma-related adverse events and exacerbations may occur during treatment.
- The UK label says patients "should not use additional long-acting β2 agonists for any reason". Do not add salmeterol, another formoterol product or another combination inhaler on top.
- Do not stop it suddenly: both labels say treatment should not be stopped abruptly in asthma because of the risk of a flare, and should be reduced under a prescriber's supervision.
Keep a fast-acting reliever such as Asthalin Rotacaps or a salbutamol inhaler for symptoms between doses. Cipla says needing more reliever than usual "indicates a deterioration of asthma control" and should be reviewed by a doctor.
How to use Maxiflo Rotacaps with a Rotahaler
Do not swallow the capsules. They work only when the powder is breathed in. Some Indian listings print steps for a pressurised inhaler ("press the inhaler"), which do not apply to Rotacaps. These steps come from Cipla's "How to use the Rotahaler" page; follow the leaflet in your pack if it differs.
- Hold the Rotahaler upright and turn the two halves so the fin is not directly below the capsule hole.
- Take out one capsule just before use and push it into the hole with the transparent end facing down.
- Open the capsule by holding the mouthpiece firmly and rotating the base.
- Breathe out fully, away from the device (our advice).
- Breathe in rapidly and deeply through your mouth, with the mouthpiece between your teeth, your lips closed tightly around it and your head tilted slightly back.
- Hold your breath for 10 seconds or as long as is comfortable, then breathe out normally. If powder remains, breathe in again.
- Open the device and throw away the empty shell. If your dose is 2 capsules, repeat with the second capsule.
- Rinse your mouth with water and spit it out. The UK label says gargling, rinsing or brushing your teeth after a dose may relieve hoarseness and thrush.
- Take it morning and evening, about 12 hours apart, every day, even when you feel well. Cipla says it "must be used daily for optimum benefit, even when asymptomatic".
- Clean the Rotahaler by separating the halves, rinsing them under clean running water, shaking off the water and leaving them to air dry. Cipla says never use it wet and never push a cloth or instrument into the mouthpiece.
Keep the capsules dry. Cipla says to keep the container "tightly closed to avoid exposure to moisture". Do not keep loose capsules in a pocket or a bathroom (our advice). Ask a doctor, nurse or pharmacist to watch your technique.
Groups who need extra care
- Heart conditions: both labels advise caution in severe cardiovascular disorders such as ischaemic heart disease, arrhythmias, severe heart failure, severe hypertension, aneurysm, hypertrophic obstructive cardiomyopathy and subvalvular aortic stenosis, and in QTc prolongation. Both say "Formoterol itself may induce prolongation of the QTc interval."
- Overactive thyroid, phaeochromocytoma, low potassium: caution (both labels). Steroid tablets, diuretics and theophylline can add to the potassium fall.
- Diabetes: both labels say extra blood sugar checks should be considered.
- Tuberculosis and chest infections: Cipla says use with caution in pulmonary tuberculosis, untreated systemic infections, eye herpes simplex and fungal, viral or other airway infections; the UK label adds quiescent tuberculosis.
- Coming off steroid tablets: both labels say take care if adrenal function may be impaired. The UK label says people who came off oral steroids "may remain at risk of impaired adrenal reserve for a considerable time".
- Severe liver disease: both labels say more exposure can be expected.
- Pregnancy: both labels say use is "not recommended" in pregnancy and should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus. Poorly controlled asthma also carries risks, so do not stop on your own; talk to your doctor.
- Breastfeeding: the UK label says a decision must be made whether to stop breastfeeding or stop treatment; Cipla says use only if the benefit is greater than any possible risk to the infant.
- Older people: no dose change (both labels).
Side effects
Neither label gives percentage rates for side effects. In the UK Flutiform table, no side effect is listed as common: the most frequent are uncommon (fewer than 1 in 100 people). Selected rows from the UK label:
| How often (UK Flutiform label) | Side effects |
|---|---|
| Uncommon (up to 1 in 100) | Headache, tremor, dizziness, palpitations, extra heartbeats, worsening of asthma, hoarseness, throat irritation, dry mouth, rash, sleep problems including insomnia |
| Rare (up to 1 in 1,000) | Thrush or fungal infection in the mouth, sinusitis, high blood sugar, abnormal dreams, agitation, taste change, vertigo, chest pain from angina, fast heartbeat, high blood pressure, breathlessness, cough, diarrhoea, indigestion, itching, muscle spasms, swelling of the ankles or legs, weakness |
| Not known | Blurred vision; hyperactivity, anxiety, depression, aggression or behaviour changes, mainly in children |
Cipla's table for Maxiflo Rotacaps follows the same layout but differs in places (for example, it lists high blood sugar and peripheral swelling as uncommon), so do not mix the two. The UK label gives the Flutiform pressurised inhaler data, not capsule data. Both labels warn that inhaled steroids can, especially at high doses over long periods, cause adrenal suppression, Cushing's syndrome, lower bone density, cataract, glaucoma and slower growth in children and adolescents. The UK label says children and adolescents under 16 on high doses of fluticasone propionate (typically 1,000 mcg a day or more) may be at particular risk of adrenal crisis, and that very rare cases have also been described at 500 to under 1,000 mcg a day. Formoterol can lower potassium and raise blood sugar. If your vision blurs, both labels say an eye specialist referral should be considered.
When to get urgent help
- A severe asthma attack, or one your reliever does not help: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia). Cipla says sudden and progressive deterioration is "potentially life-threatening" and needs urgent medical assessment. Maxiflo will not stop an attack.
- Wheezing or breathlessness that gets worse straight after a dose (paradoxical bronchospasm): use your reliever and get medical help now. Both labels say treatment should be discontinued immediately and the patient assessed.
- Your reliever working less well than usual, or needing it more often: the UK label says to be reviewed by a doctor as soon as possible.
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, hives or a widespread rash: these can be allergic reactions (the labels list angioedema and anaphylactic reactions for fluticasone). Stop the capsules and get help right away.
- Chest pain, a very fast or irregular heartbeat, fainting or a seizure.
- Drowsiness, confusion, very low blood sugar or a fit, especially during an illness, injury or surgery or after cutting the dose quickly: these can be signs of adrenal crisis, which both labels describe. Call emergency services (our advice).
- Taking far more capsules than prescribed: the labels list heart effects (fast or irregular heartbeat, angina, QTc prolongation), low potassium and seizures from formoterol overdose, and say cardiac monitoring is recommended.
Tell emergency staff which medicine you use, how many capsules you took and when.
Who should not use Maxiflo 250 Rotacaps
Never use it (contraindication): if you are allergic to fluticasone, formoterol or any other ingredient. That is the only contraindication in Cipla's and the UK labels. Truemeds says the capsules contain lactose and that people with a severe milk protein allergy should avoid them; Cipla's prescribing information lists only "Excipient q.s.", so check the carton. Cipla's text also says the capsules contain sodium cromoglycate at non-pharmacological levels, a line that matches the Flutiform label almost word for word; we could not confirm it for a capsule product.
Do not use it, or not without your doctor's agreement:
- as a reliever for an attack, or as the first treatment for asthma (UK label);
- to start treatment during a flare or when asthma is getting rapidly worse (both labels);
- together with another long-acting beta agonist (UK label);
- for COPD, which the UK Flutiform label says it should not be used for, even though Cipla lists it;
- in children under 12 (Cipla's paediatric section); the UK label limits the 250/10 strength to adults;
- with strong CYP3A4 inhibitors such as ritonavir, cobicistat, itraconazole, ketoconazole or clarithromycin: the UK label says the combination "should be avoided unless the benefit outweighs the increased risk" of steroid side effects; Cipla says avoid if possible and avoid ritonavir unless the benefit outweighs the risk, and reports Cushing's syndrome and adrenal suppression;
- with beta blockers, including glaucoma eye drops: both labels say people with asthma "should not normally be treated with" them;
- with MAO inhibitors, tricyclic antidepressants or medicines that prolong the QTc interval, without a doctor's review: Cipla says "extreme caution", the UK label says caution, including for two weeks after stopping them.
Prescription and legal status
Fluticasone propionate with formoterol is a prescription only medicine in the UK (Flutiform, POM) and a Schedule 4 prescription only medicine in Australia (Flutiform, on the PBS). We found no product with this combination in FDA records (Drugs@FDA via openFDA) or in Health Canada's Drug Product Database, so in the US and Canada it is not approved at all. In India, Apollo marks Maxiflo 250 Rotacaps as a prescription drug and Tata 1mg says "Prescription required"; the container in our product photo carries the Rx mark. This Indian pack is not registered with the FDA, the MHRA, the TGA or Health Canada. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances. Asthma needs regular review by a doctor or nurse, including an inhaler technique check and a written action plan. Check the rules where you live.
Buying genuine Maxiflo
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers this Indian Maxiflo pack. When your order arrives, check that the carton and container name Cipla and Maxiflo 250, give fluticasone propionate 250 mcg and formoterol 6 mcg, and show a batch number and an expiry date, and that the capsules are sealed and dry. These checks cannot prove a pack is genuine, because counterfeiters copy packaging. If the capsules do not seem to control your asthma the way your previous inhaler did, see your doctor rather than taking extra capsules. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Storage: Cipla says store below 30 C and do not freeze. Truemeds says below 25 C in a dry place; Apollo says 20 to 25 C. PharmEasy's storage text describes an aerosol can and a foil pouch, which does not fit Rotacaps, so we do not rely on it. Keep the capsules in their closed container, away from heat, sunlight and damp.
Delivery
We ship Maxiflo 250 Rotacaps to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days, so order at least three weeks before your capsules run out: a preventer only works if it is taken every day, and the 30 pack lasts 15 days at 1 capsule twice a day. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.
Related guides
- Rotacaps vs inhaler vs respules: which device gets the dose into your lungs
- Generic Advair and Seroflo: what the strength numbers mean
- Advair vs Symbicort (Seroflo vs Foracort): which combination inhaler
- Prednisolone for asthma flare-ups: dose, course length and risks
Other fluticasone products: Seroflo 500 Rotacaps and Seroflo 250 Inhaler (fluticasone with salmeterol), Flohale 0.5 Respules (fluticasone alone for a nebuliser). Formoterol with budesonide in the same capsule format: Foracort Forte Rotacaps.
Sources
- Cipla Limited. MAXIFLO Rotacaps (100 and 250) prescribing information, last updated February 2019, accessed 14 November 2026: composition, indications, dosage, contraindications, warnings, interactions, pregnancy, lactation, paediatric use, undesirable effects, overdosage, storage and packaging. ciplamed.com
- Flutiform 50/5, 125/5 and 250/10 micrograms per actuation pressurised inhalation, suspension. UK summary of product characteristics, Napp Pharmaceuticals, PL 16950/0167 to 0169, revised 4 June 2021, sections 2, 4.1 to 4.6, 4.8, 4.9 and 6.5; legal category POM on emc. emc
- healthdirect Australia. Flutiform 250 microgram/10 microgram: ARTG indication, Schedule 4, PBS items 10008R and 14344Y (verified 1 November 2026), accessed 14 November 2026. healthdirect
- Cipla (CiplaMed). How to use the Rotahaler, accessed 2026. ciplamed.com
- Central Drugs Standard Control Organisation, India. Fixed dose combinations approved by DCG(I) since 1961, item 533 (formoterol fumarate 6 mcg with fluticasone propionate 100, 250 or 500 mcg, dry powder inhaler and MDI, for asthma and COPD, 5 October 2006). cdsco.gov.in
- Tata 1mg, PharmEasy, Apollo Pharmacy and Truemeds. Maxiflo 250 Rotacaps listings (Cipla), accessed 14 November 2026. Tata 1mg, PharmEasy, Apollo, Truemeds
- US Food and Drug Administration. Drugs@FDA records with formoterol as an active ingredient (24 applications, none with fluticasone propionate), via openFDA, checked 14 November 2026.
- Health Canada. Drug Product Database, all products containing formoterol (none with fluticasone propionate), checked 14 November 2026. Health Canada
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), 2026 file (as of 11 November 2026): generic fluticasone propionate and salmeterol 250/50 (NDC 00054032756, 00093751831, 00527601106, 66993058597) and Wixela 250/50 (00378932132) $1.20791 per blister; Advair Diskus 250/50 (00173069600) $3.12178 per blister; all effective 21 October 2026. data.medicaid.gov
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2026: low, medium and high daily inhaled corticosteroid doses. ginasthma.org
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Fluticasone with formoterol is a prescription medicine; your doctor should set your dose, your device and your asthma action plan.
Frequently asked questions
What is Maxiflo 250 Rotacaps?
Maxiflo 250 Rotacaps are dry powder capsules made by Cipla in India. Cipla's prescribing information says each capsule contains fluticasone propionate 250 mcg (an inhaled steroid) and formoterol fumarate dihydrate 6 mcg (a long-acting bronchodilator), 30 capsules to a pack. You breathe the powder in through a Rotahaler; you do not swallow the capsules. It is a twice daily preventer for asthma, and Cipla also lists severe COPD.
Is Maxiflo 250 Rotacaps the same as Flutiform?
No. Flutiform is the licensed fluticasone propionate with formoterol inhaler in the UK and Australia, but it is a pressurised inhaler and its 250 strength gives 250 mcg fluticasone and 10 mcg formoterol per puff (metered). Maxiflo 250 Rotacaps hold 250 mcg and 6 mcg per capsule, and capsule content is neither a metered nor a delivered dose. We have not found a published study comparing the two, so treat them as related products, not identical ones.
How much does Maxiflo 250 Rotacaps cost per capsule?
As of November 2026, $17 for 30 capsules ($0.57 each), $26 for 60 ($0.43) and $38 for 90 ($0.42), before shipping. Shipping is $25 on orders under $149, so with shipping the cost is $1.40, $0.85 and $0.70 a capsule. The pack selector shows the current price. You also need a Rotahaler if you do not have one ($6).
How do I take Maxiflo 250 Rotacaps?
Put one capsule into a Rotahaler just before use, rotate the base to open it, breathe out away from the device, then breathe in rapidly and deeply through the mouthpiece and hold your breath for about 10 seconds. If powder remains, breathe in again. Throw away the empty shell and rinse your mouth with water. Cipla's dose for asthma in adults and adolescents is 1 to 2 capsules twice a day, morning and evening, every day.
Can I use Maxiflo 250 Rotacaps during an asthma attack?
No. Cipla says it should not be used to treat acute asthma symptoms that need a fast, short-acting bronchodilator, and that you should keep your reliever with you at all times. Use a reliever such as salbutamol for attacks. If an attack is severe or your reliever does not help, call emergency services.
Which Maxiflo strength should I use?
That is your doctor's decision. Maxiflo 100 Rotacap has 100 mcg fluticasone per capsule and Maxiflo 250 has 250 mcg; both have 6 mcg formoterol. At 2 capsules twice a day, Maxiflo 250 carries 1,000 mcg of fluticasone a day by capsule content, which is in GINA's high dose range. The UK limits the matching Flutiform 250/10 strength to adults, and both labels say to use the lowest dose that keeps asthma controlled.
Can Maxiflo 250 Rotacaps be used for COPD?
Cipla lists it for severe COPD at 2 capsules twice a day, and India approved the combination for asthma and COPD in 2006. The UK Flutiform label says there are no data in COPD and that it should not be used in patients with COPD. If you have COPD, ask your doctor before using it; licensed COPD inhalers with other ingredients are available.
What are the side effects of Maxiflo 250 Rotacaps?
In the UK Flutiform label the most frequent side effects are uncommon (up to 1 in 100): headache, tremor, dizziness, palpitations, hoarseness, throat irritation, dry mouth, rash, sleep problems and worsening asthma. Mouth thrush is listed as rare. Inhaled steroids at high doses over long periods can affect the adrenal glands, bones, eyes and children's growth. Rinse your mouth after each dose.
Who should not use Maxiflo 250 Rotacaps?
Anyone allergic to fluticasone, formoterol or another ingredient must not use it; Truemeds says the capsules contain lactose, so avoid them with a severe milk protein allergy. It is not for children under 12 (Cipla) or for starting asthma treatment (UK label), and should not be combined with another long-acting beta agonist. Strong CYP3A4 inhibitors such as ritonavir and beta blockers need a doctor's review first.
Do I need a prescription for Maxiflo 250 Rotacaps?
Fluticasone with formoterol is prescription only in the UK and Australia, where it is licensed as Flutiform. We found no approved product with this combination in the US or Canada. Indian pharmacies sell Maxiflo on prescription. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada, and the FDA says personal importation of unapproved medicines is illegal in most circumstances.
How long does delivery take?
Delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is $25 under $149 and free from $149. Order at least three weeks before you run out: the 30 pack lasts only 15 days at 1 capsule twice a day.
Medical References
- 1.ciplamed.com
- 2.emc
- 3.healthdirect
- 4.ciplamed.com
- 5.cdsco.gov.in
- 6.Tata 1mg
- 7.PharmEasy
- 8.Apollo
- 9.Truemeds
- 10.Health Canada
- 11.data.medicaid.gov
- 12.ginasthma.org
- 13.GOV.UK
- 14.FDA
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Maxiflo 250 Rotacaps? Tell other buyers how it went.







